EEG and ECG Biometrics Market By Product (EEG Biometric Devices, ECG Biometric Devices, Multimodal EEG and ECG Biometric Systems, Biometric Software and Platforms, Services); By Application (Identity Authentication and Access Control, Liveness Detection and Continuous Authentication, Health Monitoring and Clinical Biosensing, Behavioral and Cognitive Assessment, Research and Development); By End User (Healthcare Organizations, Enterprises and Industrial Facilities, Research and Academic Institutions, Government and Defense Organizations, Consumer Electronics and Wellness Companies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

EEG and ECG Biometrics Market: Physiological Signals Advance into Continuous Authentication

The Global EEG and ECG Biometrics Market was valued at USD 2.24 billion in 2025 and is projected to reach USD 4.45 billion by 2032, expanding at a CAGR of 10.3% during 2026–2032, according to Strategic Market Research.

 

EEG- and ECG-based biometrics are gaining attention as tools for identity verification and continuous health assessment. These systems use brainwave and cardiac signal patterns, which can vary from person to person, to support ongoing user recognition. Devices such as portable ECG monitors and combined EEG/ECG platforms provide the physiological data required for analysis. Artificial intelligence then processes these signals, identifies distinctive features, and enables real-time authentication or clinical monitoring.

 

ECG Holds the Strongest Near-Term Commercial Position

ECG accounted for an estimated 67.0% of the market in 2025, equivalent to approximately USD 1.50 billion, and is projected to expand at a CAGR of 9.8% through 2032. EEG represented the remaining 33.0%, or about USD 0.74 billion, but is forecast to grow faster at 11.3% as in-ear sensors, dry electrodes, brain-computer interfaces, and neural-signal authentication move beyond research settings.

ECG is closer to practical biometric use because cardiac signals can be captured through wristbands, chest sensors, handheld devices, vehicle controls, and other contact surfaces. This makes ECG suitable for repeated identity checks and liveness confirmation without requiring a separate authentication procedure.

Nymi provides one of the clearest commercial examples. The Nymi Band authenticates the wearer through a fingerprint sensor, while ECG can be enabled as a liveness check. The cardiac signal confirms that the device is being worn by a living person rather than acting as the primary identity matcher.

Nymi focuses on regulated and industrial workplaces where employees repeatedly access terminals, controlled rooms, production systems, and electronic records. Its use cases include passwordless login, electronic signatures, physical access, manufacturing execution systems, human-machine interfaces, and distributed-control environments.

Innominds reported in 2022 that Nymi had deployments across 15 countries and served nine of the ten largest pharmaceutical manufacturers globally. The deployment pattern demonstrates the value of wearable authentication in settings where shared terminals, protective clothing, and strict traceability requirements make repeated password entry inefficient.

ECG also benefits from wider development in wearable cardiac technology. AliveCor’s KardiaMobile Card, VivaLNK’s Continuous ECG Platform, and B-Secur’s HeartKey Rhythm have received U.S. regulatory clearance for ECG recording or rhythm analysis. These products are not identity systems, but they expand the availability of validated sensors, compact form factors, signal-quality tools, and embedded algorithms.

B-Secur’s HeartKey Rhythm analyzes ambulatory ECG data and can be integrated into Holters, patches, and event recorders. The company reports more than 7 billion heartbeats and 2 million hours of ECG data analyzed. This processing scale reflects the rising value of software capable of converting raw cardiac signals into reliable outputs for medical, wearable, and embedded applications.

 

EEG Authentication Is Moving Beyond Research

EEG authentication remains less mature because reliable brain-signal capture requires closer sensor placement and stronger control of motion, electrode contact, and environmental interference. Brain activity also changes with fatigue, stress, attention, and mental tasks, which can reduce consistency between enrollment and later authentication attempts.

Commercial interest is increasing. In November 2025, NeuroSky and ZKTeco announced a joint venture focused on brain-computer-interface and emotion-recognition technologies. EEG identity authentication was identified among its initial applications, together with workforce attention training and emotional-wellness products.

The partnership combines NeuroSky’s neural-signal technology with ZKTeco’s access-control and biometric experience. This is commercially important because EEG authentication requires more than neuroscience hardware. It also needs identity-management software, secure access infrastructure, electronics manufacturing, enterprise integration, and distribution channels.

NeuroSky reports that more than 1 million TGAM EEG modules are in circulation. These modules support education, wellness, entertainment, and research rather than identity authentication alone. Their broad availability still lowers development costs for companies testing brain-signal classification and related biometric applications.

EMOTIV, IDUN Technologies, Advanced Brain Monitoring, and iMotions support the wider EEG ecosystem. EMOTIV supplies EEG headsets and research software. IDUN is developing in-ear EEG products intended to make signal collection less intrusive. Advanced Brain Monitoring provides systems that acquire EEG, ECG, and other physiological signals, while iMotions synchronizes EEG and ECG with eye tracking, facial-expression analysis, and other biosensors.

These companies generate revenue through hardware, software subscriptions, research platforms, and application-development tools. Their technologies also expand the datasets and testing environments needed for future EEG authentication products.

 

AI and Signal Processing Drive Market Value

Hardware, including sensors, modules, headsets, wearables, and integrated monitoring devices, held an estimated 55.0% market share in 2025 and generated approximately USD 1.23 billion. Hardware is forecast to grow at 8.9% through 2032. Software and services accounted for 45.0%, or about USD 1.01 billion, and are projected to expand at 11.9%, supported by algorithm licensing, cloud and edge processing, device management, subscriptions, and enterprise integration.

The largest share of incremental commercial value is moving toward software. Raw EEG and ECG signals contain motion artifacts, poor-contact noise, physiological variation, and device-related differences. Algorithms must clean the signal, isolate useful patterns, create an enrollment template, and compare later recordings with that template.

ECG models may evaluate cardiac-cycle shape, timing, and waveform relationships. EEG systems may assess frequency patterns, responses to stimuli, or activity generated during selected mental tasks. Machine learning can identify signal relationships that fixed measurements may miss, but performance in controlled studies does not always translate into dependable workplace or consumer use.

Cross-session reliability is one of the main barriers. A model may perform well when enrollment and testing samples come from the same recording but weaken when the user returns on another day, changes posture, exercises, experiences stress, or uses a different sensor. Commercial systems must maintain acceptable false-acceptance and false-rejection rates across changing conditions.

This creates demand for larger datasets, independent testing, and consistent performance benchmarks. Buyers will increasingly assess enrollment failure, long-term accuracy, motion tolerance, spoofing resistance, sensor compatibility, and performance across different users and environments.

On-device processing can improve the commercial case. Running classification on a wearable or local controller reduces latency, limits cloud dependence, and keeps raw physiological data closer to the user. These benefits are particularly relevant in factories, vehicles, healthcare facilities, and secure locations where connectivity or data movement may be restricted.

Automated EEG-processing frameworks also support market development by improving consistency in artifact removal, analysis, and model preparation. These platforms shorten development cycles and help research teams compare results more effectively, strengthening the software and services segment of the market.

 

Connected-Worker Authentication Forms the Core Revenue Base

By application, clinical biosensing and health monitoring represented an estimated 46.0% of 2025 revenue, or approximately USD 1.03 billion, and are forecast to grow at 9.2% through 2032. Identity authentication and access control accounted for 32.0%, equivalent to about USD 0.72 billion, and are projected to record the fastest application CAGR of 12.4%. Research, wellness, and behavioral assessment contributed the remaining 22.0%, or nearly USD 0.49 billion, with a projected CAGR of 9.3%.

Enterprise authentication currently provides the clearest revenue opportunity within the core biometric segment. Pharmaceutical manufacturing, laboratories, cleanrooms, utilities, logistics operations, and industrial sites require employees to access multiple systems while maintaining accurate records of each action.

Wearable authentication can connect one identity to terminals, equipment interfaces, electronic signatures, and physical access points throughout a shift. This reduces repeated credential entry and lowers dependence on shared passwords or transferable access cards.

The revenue model includes initial wearables, sensing components, platform licenses, device management, system integration, support, and replacement hardware. Deployment can expand from one facility or application into multiple sites, workforce groups, and authentication processes, increasing recurring software and service income.

ECG is well suited to this market as an additional authentication factor. NIST digital-identity guidance requires two distinct factors at Authentication Assurance Level 2 and does not recognize a biometric characteristic as an authenticator by itself. This favors systems that combine a secure wearable, local biometric verification, physiological liveness, and encrypted communication.

 

Clinical Biosensing Strengthens the Adjacent Technology Base

Healthcare was the largest end-user segment in 2025, accounting for an estimated 43.0% share and approximately USD 0.96 billion in revenue. It is forecast to expand at 9.4% through 2032. Enterprise and industrial users represented 31.0%, or about USD 0.69 billion, and are projected to post the fastest end-user CAGR of 12.2%. Research institutions, developers, and consumer-wellness users accounted for 26.0%, equivalent to approximately USD 0.58 billion, with a projected CAGR of 9.4%.

Healthcare supports large volumes of EEG and ECG collection, algorithm development, and wearable-device innovation. Clinical demand expands the technology base even though patients receiving cardiac or neurological monitoring are not automatically users of biometric authentication.

At least 10.55 million U.S. adults had diagnosed atrial fibrillation at the end of 2019. Globally, approximately 52.55 million people were living with atrial fibrillation or flutter in 2021. These populations support demand for ambulatory ECG recording, rhythm classification, signal-quality assessment, and remote monitoring.

EEG has an established clinical base in epilepsy and seizure assessment. CDC estimates indicate that approximately 2.9 million U.S. adults had active epilepsy during 2021–2022, while about 456,000 children had active epilepsy in 2022. WHO estimates that around 50 million people live with epilepsy worldwide and approximately 5 million new cases are diagnosed annually.

These patient populations sustain investment in electrodes, wearable form factors, long-duration recording, artifact removal, and signal interpretation. Improvements made for clinical monitoring can later support research, wellness, and identity-related applications.

Regulated clinical products can also strengthen supplier credibility. FDA clearance for an EEG- or ECG-related product demonstrates experience with validation, quality systems, data integrity, and regulated development. Companies operating across medical and non-medical markets may therefore gain an advantage when supplying original-equipment manufacturers, research institutions, and enterprise-platform providers.

 

Privacy and Performance Standards Shape Adoption

EEG and ECG data can reveal more than identity. The same recording may contain information associated with cardiac rhythm, fatigue, stress, neurological activity, or other physiological conditions. This raises greater privacy concerns than conventional passwords or access tokens.

European and UK data-protection rules treat biometric information used for unique identification as specially protected data. Depending on how the signal is analyzed, it may also qualify as health information. Companies need clear consent procedures, controlled access, defined retention periods, deletion policies, and restrictions on secondary use.

Performance testing remains less established than for fingerprint, face, and iris recognition. EEG and ECG systems need stronger evidence across separate recording sessions, sensor changes, movement, spoofing attempts, long-term use, and varied user groups. Independent validation will become more important as buyers move from pilots to larger deployments.

 

Competition Spans Authentication, Sensors, Algorithms, and Research Platforms

The competitive landscape is divided across several supplier groups.

Nymi is the most direct enterprise-authentication participant, combining a wearable credential, fingerprint recognition, optional ECG liveness, and connected-worker software.

B-Secur, AliveCor, VivaLNK, and NeuroSky participate through ECG sensors, modules, and signal-processing technology. Their main products focus on monitoring or analysis, but their hardware and software capabilities can support future biometric integration.

NeuroSky, EMOTIV, IDUN Technologies, and Advanced Brain Monitoring contribute EEG hardware, research platforms, and developer tools. Their products expand access to brain-signal data and reduce the cost of testing new applications.

ZKTeco brings access-control experience to the NeuroSky partnership, while iMotions represents multimodal research software. Multimodal systems combine EEG or ECG with fingerprint, facial recognition, photoplethysmography, eye tracking, device possession, or behavioral information to improve liveness and reduce spoofing risk.

 

Regional Market Direction

North America led the market with an estimated 39.0% share in 2025, equivalent to approximately USD 0.87 billion, and is projected to expand at a CAGR of 9.7% through 2032. The region has the clearest combination of enterprise deployments, wearable development, research platforms, and regulatory experience. Nymi operates from Canada, while NeuroSky, EMOTIV, AliveCor, and VivaLNK have major U.S. operations. Large pharmaceutical, healthcare, technology, and industrial customers also support controlled biometric deployments.

Europe accounted for an estimated 28.0% of 2025 revenue, or about USD 0.63 billion, and is forecast to grow at 9.8%. The region has strong capabilities in ECG algorithms, in-ear EEG, multimodal research, and medical-device development. B-Secur is based in Belfast, IDUN Technologies in Switzerland, and iMotions in Denmark. Regional data-protection requirements raise compliance costs but also encourage privacy-focused architecture and local processing.

Asia Pacific represented approximately 25.0% of the market, equal to USD 0.56 billion in 2025, and is projected to record the fastest regional CAGR of 12.0%. The region is central to sensor manufacturing, electronics integration, and access-control commercialization. ZKTeco’s participation in EEG authentication gives China a direct role in connecting neural-signal technology with biometric infrastructure. The NeuroSky-ZKTeco venture also points to a broader commercialization network spanning Asia, North America, Europe, and the Middle East. The remaining regions accounted for about 8.0%, or USD 0.18 billion, and are forecast to grow at 9.4%.

 

Market Outlook

ECG is expected to retain the stronger near-term commercial position because it can be collected through practical wearable and contact-based devices. Its main opportunities are likely to involve liveness detection, repeated presence verification, and multifactor authentication.

EEG offers broader long-term possibilities but faces greater usability and reliability challenges. In-ear sensors, dry electrodes, compact headsets, and embedded processors may make brain-signal collection more practical. Commercial adoption will depend on stable performance across different days, devices, environments, and mental states.

Multimodal systems will shape the next stage of competition. Combining physiological signals with established identity methods can improve security while reducing dependence on one modality. Successful products will balance accuracy, privacy, speed, user acceptance, and compatibility with existing access systems.

 

EEG And ECG Biometrics Market Report Coverage Table

Report Attribute	Details
Forecast Period	2026 – 2032
Market Size Value in 2025	USD 2.24 Billion
Revenue Forecast in 2032	USD 4.45 Billion
Overall Growth Rate	CAGR of 10.3% (2026 – 2032)
Base Year for Estimation	2025
Historical Data	2019 – 2024
Unit	USD Million, CAGR (2026 – 2032)
Segmentation	By Product, By Application, By End User, By Geography
By Product	EEG Biometric Devices, ECG Biometric Devices, Multimodal EEG and ECG Biometric Systems, Biometric Software and Platforms, Services
By Application	Identity Authentication and Access Control, Liveness Detection and Continuous Authentication, Health Monitoring and Clinical Biosensing, Behavioral and Cognitive Assessment, Research and Development
By End User	Healthcare Organizations, Enterprises and Industrial Facilities, Research and Academic Institutions, Government and Defense Organizations, Consumer Electronics and Wellness Companies
By Region	North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Country Scope	U.S., Canada, UK, Germany, France, Italy, China, Japan, South Korea, India, Brazil, Mexico, Saudi Arabia, UAE, South Africa
Market Drivers	Growing demand for secure biometric authentication, increasing adoption of AI-enabled biosensing technologies, rising interest in continuous health monitoring, and expansion of digital identity and security applications
Customization Option	Available upon request